Polish Registry of Takotsubo Syndrome | Clinical Trial

Key information

Conditions

Takotsubo Syndrome Cardiomyopathies Cardiovascular Diseases Heart Diseases Takotsubo Cardiomyopathy Ventricular Dysfunction Ventricular Dysfunction, Left

Sex eligibility

All sexes

Study type

Observational

Primary location

Medical University of Warsaw

Warsaw, Poland

Location status: Recruiting

Location contact

Grzegorz Opolski, Prof

PRINCIPAL_INVESTIGATOR

Monika Budnik

CONTACT

Radosław Piątkowski, PhD

SUB_INVESTIGATOR

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

all patients with takotsubo syndrome

Exclusion criteria

-

Treatment and study plan

No intervention

Other

No intervention

Primary outcomes

Number of participants with in-hospital complications and mortality

Time frame: through study completion, an average of 1 year

In hospital complications include atrial fibrillation, ventricular tachycardia, ventricular fibrillation, atrioventricular block, cardiogenic shock, cardiac arrest

Secondary outcomes

Number of participants with complications with echocardiography

Time frame: through study completion, an average of 1 year

Complications include: severe mitral regurgitation, fluid in the pericardium, right ventricle disfunction, ventricular septum rupture

Study contacts

Contact information is provided by the study sponsor or research team.

Monika Budnik, PhD

CONTACT

[email protected]

+48225991958

Sponsors and collaborators

Lead sponsor

Medical University of Warsaw

Other

Registry information

Acronym: Pol-Tako

Important dates

Study start: 2020
Primary completion: 2021
Study completion: 2030
First posted: Nov 18, 2020
Registry last updated: Nov 18, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Recruiting